To get a sense of who is truly in control of Silence Therapeutics plc (NASDAQ:SLN), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of ...

Some of Julia Donaldson and Axel Scheffler’s most popular characters are set to appear on BBC One and BBC iPlayer in three brand new idents this Christmas. The festive visuals will showcase a range of ...

The idents feature much-loved characters from the magical adaptations of Julia Donaldson and Axel Scheffler’s picture books Magic Light Pictures have created three charming new idents exclusively for ...

One thing we could say about the analysts on Silence Therapeutics plc (NASDAQ:SLN) - they aren't optimistic, having just made a major negative revision to their near-term (statutory) forecasts for the ...

Writing from the Chicagoland area in Illinois, Robert is an avid movie watcher and will take just about any excuse to find time to go to his local movie theaters. Robert graduated from Bradley ...

Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...

Sentinel lymph node (SLN) biopsy for early cervical cancer achieved non-inferiority versus pelvic lymphadenectomy, according to results of a large randomized study from China. Patients assigned to SLN ...

It's hard to believe, but Friday marks 10 years since the final major storm of Boston's record-breaking winter in 2015 - a season that buried the city under an unbelievable 110.6 inches of snow. From ...

Goldman Sachs initiated Silence Therapeutics (NASDAQ:SLN) with a Sell rating and a $6 price target on Tuesday, arguing that with only about $173M of cash and equivalents at the end of Q3 2024, the U.K ...

A worker clears his truck after unloading plowed snow at a "snow farm" in Boston's Seaport. (Michael Dwyer/AP) Editor's Note: This is an excerpt from WBUR's daily morning newsletter, WBUR Today. If ...

Shares of Silence Therapeutics SLN plunged 36.8% on Tuesday despite reporting positive end-of-treatment data from a mid-stage study of lead candidate, zerlasiran, to treat atherosclerotic ...